When OpenAI unveiled ChatGPT Health in January 2026, it promised a “global grounding” in medicine, backed by 260 physicians across 60 countries. But for the African healthtech ecosystem, the launch highlighted a familiar friction: global AI is only as good as the data that built it, and that data remains overwhelmingly Western.
In a region where diagnosis often happens without a doctor, these gaps are dangerous. ChatGPT Health may master diabetes management, but it remains blind to the local surge in counterfeit antimalarials or the seasonal nuances of malaria transmission. It can recommend a blood test routine in London that is physically unavailable in Kano.
And still, the appetite for medical AI is already here. Nigerians are part of the 40 million daily medical queries OpenAI reports globally. In a country where 70% of the population self-medicates, millions now use AI to “pre-consult” before deciding if a clinic visit is worth the cost. This is where a new class of African GenAI startups—like KOYO, Awadoc, MyItura, and Zuri Health—are digging their moats.
This story is for Condia Insiders only.
Keep reading free. Join the community at the forefront of African tech.
Already an Insider? Sign in
Last updated: January 21, 2026
